|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 107.2 USD | +0.30% |
|
+0.10% | -2.43% |
| 12:29am | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
| 12:21am | Edwards Lifesciences first-quarter profit beats estimates on heart devices strength | RE |
By Matt Grossman
Abbott Laboratories said Tuesday that it expects to log full-year adjusted earnings of at least $5 a share.
Analysts surveyed by FactSet had been forecasting adjusted earnings per share of $5.06 for 2021.
Abbott said it was anticipating unadjusted earnings of at least $3.74 a share.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
04-20-21 0808ET
| 1st Jan change | Capi. | |
|---|---|---|
| -2.43% | 185B | |
| -3.82% | 105B | |
| -5.44% | 66.59B | |
| +4.96% | 54.66B | |
| +16.43% | 47.78B | |
| +4.06% | 41.26B | |
| +3.69% | 26.95B | |
| +2.44% | 26.37B | |
| +12.96% | 24.8B | |
| -1.90% | 24.6B |
ABBOTT LABORATORIES 
